Valley surgeon heads up test of aneurysm treatment - Business First of Louisville:

cahijisebi.wordpress.com
Rodriguez, the director of peripheral vascularr services at the ArizonaHeart Institute, has been named the nationak principal investigator for the Phase II study, whic is required by the to enroll 160 patients. The Arizonas Heart Institute is one of 14 centersa involved in thestudy nationwide. “We are looking to includee at least six more centers to complete 20 centers inthe U.S.,” Rodriguez said. The endolumina graft is manufactured bynear Glasgow, Called the Anaconda Stent Graft System, it allows the surgeomn to reposition the device once it has been placed acrosse the aneurysm.
So far, nearly 4,000 patientsx in Europe have received theAnacondza device, but it must get approval from the FDA befors it can be used in the U.S. Rodriguezx said the minimally invasive procedurde onthe study’s first patient went saying the device is very easy to use. “Hr was up on his feet the next morning having Rodriguez said ofthe patient. “You can’t do that when you open the This eliminates the need for openhearft surgery.” Abdominal aortic aneurysm, or of the body’s main is a serious condition prone to rupture and lead to suddenb death. Actor John Ritter died of an aortif rupturein 2003.
Symptoms can occur suddenlyt with severe, sharp pain in the abdomen. Patients who experienc e these symptoms should seek immediatremedical attention, Rodriguez said. Early detection can prevent suddehn death. Patients with a family history of aorticd aneurysm or other connective tissue disorders shouls notify their physician about their risk ofaorti aneurysm, he said.